Evidence map›Paper›PMID 39565121›Full record

ArticleJournal of clinical microbiology2024

Characterization of carbapenem-resistant Enterobacterales and

Sarah Sabour, Kristin R V Harrington, Ellen Martinson, Amelia S Bhatnagar, Jennifer Y Huang, Dustin Duffy, Katie Bantle, Joseph D Lutgring, Maria Karlsson, Allison C Brown

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2026
    Review
  2. Review
  3. In vitro activity of the novel β-lactamase inhibitor FL058 combined with meropenem against KPC- or NDM-producing enterobacterales and Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. AMRrounds: Metallo-β-lactamase-producingJAC-antimicrobial resistance · 2025
    Article
  5. Article
  6. Article
  7. Plasmid genomic epidemiology ofMicrobial genomics · 2025
    Article
  8. Evolution of Resistant Mutants inMicroorganisms · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah Sabour *Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4803-3704
Kristin R V Harrington *Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.ORCID 0000-0002-9306-4980
Ellen MartinsonDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Amelia S BhatnagarDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-3859-0328
Jennifer Y HuangDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-2635-9372
Dustin DuffyDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Katie BantleDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Joseph D LutgringDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-5723-8317
Maria KarlssonDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.ORCID 0000-0002-2463-0598
Allison C BrownDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-0011-0309

Funding

HHS | Centers for Disease Control and Prevention (CDC)
6 · The paper itself

Abstract

Carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsMicrobial Sensitivity TestsPseudomonas aeruginosaEnterobacteriaceae InfectionsGenotypeHumansPseudomonas InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenemase genescarbapenem resistanceEnterobacteralesPseudomonas aeruginosa

Identifiers

PMID39565121
PMCPMC11633150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.